SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

West Pharma sees FY adjusted EPS of $9.38-$9.48

WST
SquawkNews Desk 2 updates Updated Oct 29, 2026, 10:14 AM UTC

Story updates

10:01:02 AM UTC
SquawkNews
West Pharma Sees FY EPS $9.31-EPS $9.41 >WST
10:14:30 AM UTC
SquawkNews
*--GUIDANCE: (WST) West Pharmaceutical Services Expects 2026 Adjusted EPS Range $9.38 to $9.48, vs. FactSet Est of $8.98

Related stories

SCOR Q3 Net Income Falls as Catastrophe Losses Rise France-based reinsurer SCOR reported lower Q3 net income as catastrophe losses rose. M impact | EARNINGS | Oct 30, 2026, 06:12 AM UTC Toyota Industries H1 Profit Surges on Higher Revenues Toyota Industries reported that first-half profit attributable to owners of the parent nearly doubled, alongside strong revenue growth. H impact | EARNINGS | Oct 30, 2026, 06:04 AM UTC DHI FY2026 profit falls 19.41% DHI reported FY2026 profit attributable to shareholders of 28.89亿美元, down 19.41% year over year. Basic EPS was 10.14美元. M impact | EARNINGS | Oct 30, 2026, 05:41 AM UTC Starbucks sees higher profit ahead amid turnaround progress Starbucks expects higher profit, citing progress in its turnaround. M impact | EARNINGS | Oct 30, 2026, 05:25 AM UTC Sensex Edges Higher on Tech Stocks India’s BSE Sensex edged up about 0.2% to 74,319 on Friday, extending gains from the previous session as buying in IT stocks and optimism over corporate earnings helped offset pres H impact | EARNINGS | Oct 30, 2026, 04:53 AM UTC BYD Electronic Reports Higher Revenue, Lower Profit for First Three Quarters BYD Electronic reported revenue growth but a decline in net profit for the first three quarters. M impact | EARNINGS | Oct 30, 2026, 04:49 AM UTC